Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1769772

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1769772

Throat Cancer Global Market Report 2025

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Throat cancer is characterized by the development of malignant cells within the throat tissues, encompassing areas such as the pharynx, larynx, and tonsils. Common symptoms include a persistent sore throat, hoarseness, and difficulty swallowing. The condition is frequently associated with risk factors like tobacco use, alcohol consumption, and infection with the human papillomavirus (HPV).

There are two primary forms of throat cancer: pharyngeal cancer and laryngeal cancer. Pharyngeal cancer arises in the pharynx-the section of the throat located behind the nose and mouth-and can impact specific regions including the nasopharynx, oropharynx, and hypopharynx. Available treatments range from surgery and radiation therapy to chemotherapy, targeted therapy, antimetabolites, platinum-based drugs, plant-derived treatments, nitrogen mustard agents, antibiotics, and others. These therapies are administered across various end-user settings such as hospitals, multispecialty clinics, cancer research centers, and ambulatory surgical units.

The throat cancer market research report is one of a series of new reports from The Business Research Company that provides throat cancer market statistics, including the throat cancer industry's global market size, regional shares, competitors with the throat cancer market share, detailed throat cancer market segments, market trends and opportunities, and any further data you may need to thrive in the throat cancer market. This throat cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The throat cancer market size has grown strongly in recent years. It will grow from $2.25 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. Growth during the historical period was supported by an increase in smoking rates, a surge in alcohol consumption, a rise in HPV infections, greater prevalence of gastroesophageal reflux disease (GERD), and worsening urban air pollution levels.

The throat cancer market size is expected to see strong growth in the next few years. It will grow to $3.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. Projected growth will be driven by increased demand for personalized medicine, broader adoption of tele-oncology and advanced diagnostics, greater use of genetic profiling and biomarkers, rising popularity of vaping and e-cigarettes, and an uptick in obesity and sedentary lifestyles. Key trends anticipated in the forecast period include innovations in treatment approaches, enhanced diagnostic tools using novel technologies, the emergence of new drugs and therapies, use of AI and machine learning for predictive diagnostics, and the digital integration of speech therapy solutions.

The rise in the smoking population is anticipated to drive the growth of the throat cancer market in the coming years. The smoking population refers to the proportion or number of individuals in a specific area who consistently consume tobacco products. This population is increasing due to higher stress levels, prompting more individuals to turn to smoking as a coping strategy. Throat cancer highlights the serious health risks associated with smoking, underscoring the urgent need for public awareness and preventive efforts to reduce its occurrence among smokers. For example, in October 2024, the European Respiratory Society (ERS), a Switzerland-based non-profit organization, reported a significant increase in smoking rates among young people, rising from 22.5% in 2022 to 40.1% in 2024. As a result, the growing smoking population is contributing to the expansion of the throat cancer market.

Leading companies in the throat cancer market are emphasizing the development of innovative therapies, such as immuno-oncology drugs, to improve treatment effectiveness and patient survival rates. Immuno-oncology drugs utilize the body's immune system to detect and destroy cancer cells, offering a more targeted and efficient treatment approach. For instance, in November 2024, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical company, launched Toripalimab to treat nasopharyngeal carcinoma, a rare and aggressive type of throat cancer. This innovative therapy leverages immune checkpoint inhibition by targeting the PD-1 receptor, thereby enabling the immune system to better recognize and eliminate cancer cells. Toripalimab provides a new therapeutic option for patients with limited choices, potentially enhancing survival outcomes and quality of life.

In January 2024, Inovio Pharmaceuticals Inc., a US-based biotechnology company, entered into a partnership with Coherus BioSciences to advance DNA-based immunotherapies for cancer. The collaboration aims to accelerate the development of INO-3112 in combination with LOQTORZ to treat HPV-associated cancers more effectively. Through this partnership, the companies seek to improve patient outcomes by utilizing cutting-edge immunotherapy methods. Coherus BioSciences Inc. is a US-based firm specializing in the development and commercialization of immuno-oncology treatments for difficult-to-treat cancers.

Major players in the throat cancer market are Pfizer Inc., Roche Holding AG, Merck and Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories, Biocon Ltd., Coherus BioSciences Inc., Inovio Pharmaceuticals Inc., Boston Biomedical Inc., Shanghai Sunway Biotech Co. Ltd., and Odon Life Sciences.

North America was the largest region in the throat cancer market in 2024. The regions covered in throat cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the throat cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The throat cancer market consists of revenues earned by entities by providing services such as diagnostic services, immunotherapy services, palliative care services, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The throat cancer market also includes sales of chemotherapy drugs, radiation therapy equipment, immunotherapy drugs, targeted therapy drugs, and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Throat Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on throat cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for throat cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The throat cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Types: Pharyngeal Cancer; Laryngeal Cancer
  • 2) By Treatments: Surgery; Radiation Therapy; Targeted Therapy; Chemotherapy; Antimetabolites; Platinum Derivatives; Plant Derivatives; Nitrogen Mustards; Antibiotics; Other Treatments
  • 3) By End-User: Hospitals; Cancer Research Institutes; Multispecialty Clinics; Ambulatory Surgical Centers

Subsegments

  • 1) By Pharyngeal Cancer: Oropharyngeal Cancer; Nasopharyngeal Cancer; Hypopharyngeal Cancer
  • 2) By Laryngeal Cancer: Glottic Cancer; Supraglottic Cancer; Subglottic Cancer
  • Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck and Co. Inc.; AbbVie Inc.; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r36090

Table of Contents

1. Executive Summary

2. Throat Cancer Market Characteristics

3. Throat Cancer Market Trends And Strategies

4. Throat Cancer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Throat Cancer Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Throat Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Throat Cancer Market Growth Rate Analysis
  • 5.4. Global Throat Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Throat Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Throat Cancer Total Addressable Market (TAM)

6. Throat Cancer Market Segmentation

  • 6.1. Global Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharyngeal Cancer
  • Laryngeal Cancer
  • 6.2. Global Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgery
  • Radiation Therapy
  • Targeted Therapy
  • Chemotherapy
  • Antimetabolites
  • Platinum Derivatives
  • Plant Derivatives
  • Nitrogen Mustards
  • Antibiotics
  • Other Treatments
  • 6.3. Global Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cancer Research Institutes
  • Multispecialty Clinics
  • Ambulatory Surgical Centers
  • 6.4. Global Throat Cancer Market, Sub-Segmentation Of Pharyngeal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oropharyngeal Cancer
  • Nasopharyngeal Cancer
  • Hypopharyngeal Cancer
  • 6.5. Global Throat Cancer Market, Sub-Segmentation Of Laryngeal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glottic Cancer
  • Supraglottic Cancer
  • Subglottic Cancer

7. Throat Cancer Market Regional And Country Analysis

  • 7.1. Global Throat Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Throat Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Throat Cancer Market

  • 8.1. Asia-Pacific Throat Cancer Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Throat Cancer Market

  • 9.1. China Throat Cancer Market Overview
  • 9.2. China Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Throat Cancer Market

  • 10.1. India Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Throat Cancer Market

  • 11.1. Japan Throat Cancer Market Overview
  • 11.2. Japan Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Throat Cancer Market

  • 12.1. Australia Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Throat Cancer Market

  • 13.1. Indonesia Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Throat Cancer Market

  • 14.1. South Korea Throat Cancer Market Overview
  • 14.2. South Korea Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Throat Cancer Market

  • 15.1. Western Europe Throat Cancer Market Overview
  • 15.2. Western Europe Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Throat Cancer Market

  • 16.1. UK Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Throat Cancer Market

  • 17.1. Germany Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Throat Cancer Market

  • 18.1. France Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Throat Cancer Market

  • 19.1. Italy Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Throat Cancer Market

  • 20.1. Spain Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Throat Cancer Market

  • 21.1. Eastern Europe Throat Cancer Market Overview
  • 21.2. Eastern Europe Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Throat Cancer Market

  • 22.1. Russia Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Throat Cancer Market

  • 23.1. North America Throat Cancer Market Overview
  • 23.2. North America Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Throat Cancer Market

  • 24.1. USA Throat Cancer Market Overview
  • 24.2. USA Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Throat Cancer Market

  • 25.1. Canada Throat Cancer Market Overview
  • 25.2. Canada Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Throat Cancer Market

  • 26.1. South America Throat Cancer Market Overview
  • 26.2. South America Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Throat Cancer Market

  • 27.1. Brazil Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Throat Cancer Market

  • 28.1. Middle East Throat Cancer Market Overview
  • 28.2. Middle East Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Throat Cancer Market

  • 29.1. Africa Throat Cancer Market Overview
  • 29.2. Africa Throat Cancer Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Throat Cancer Market, Segmentation By Treatments, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Throat Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Throat Cancer Market Competitive Landscape And Company Profiles

  • 30.1. Throat Cancer Market Competitive Landscape
  • 30.2. Throat Cancer Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Throat Cancer Market Other Major And Innovative Companies

  • 31.1. Bristol Myers Squibb
  • 31.2. AstraZeneca plc
  • 31.3. Novartis AG
  • 31.4. GlaxoSmithKline plc
  • 31.5. Takeda Pharmaceutical Company Limited
  • 31.6. Eli Lilly and Company
  • 31.7. Amgen Inc.
  • 31.8. Astellas Pharma Inc.
  • 31.9. Dr. Reddy's Laboratories
  • 31.10. Biocon Ltd.
  • 31.11. Coherus BioSciences Inc.
  • 31.12. Inovio Pharmaceuticals Inc.
  • 31.13. Boston Biomedical Inc.
  • 31.14. Shanghai Sunway Biotech Co. Ltd.
  • 31.15. Odon Life Sciences

32. Global Throat Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Throat Cancer Market

34. Recent Developments In The Throat Cancer Market

35. Throat Cancer Market High Potential Countries, Segments and Strategies

  • 35.1 Throat Cancer Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Throat Cancer Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Throat Cancer Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!